| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C04B35-632 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
| filingDate |
2004-10-06^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705d5fa4561c834e87b5be8c506a2f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f65ccda9667abf55ea0f3809684db34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ade41c25d30738875acb623bf600ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59cecbb73868445689820aefea384182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db454f3505c4dcccfef3f32c774d24dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6731b5a045165c4392d9ce9d8b87c907 |
| publicationDate |
2007-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007072900-A1 |
| titleOfInvention |
P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| abstract |
The bioavailability of an anticancer agent is enhanced when the anticancer agent is administered together with a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113631161-A |
| priorityDate |
2003-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |